Target intelligence / Profile preview

Intestinal epithelial cell surface mannose-containing glycoproteins

Molecular classification
Glycoprotein, Cell surface receptor, Cell adhesion molecule
01

Overview

Intestinal epithelial cell surface mannose-containing glycoproteins are a group of membrane-bound proteins characterized by the presence of mannose-rich oligosaccharide chains, with Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) being the most prominent member (Barnich et al., J Clin Invest, 2007). These glycoproteins are primarily located on the apical surface of enterocytes and play physiological roles in cell-cell adhesion and innate immune signaling (Sivignon et al., Expert Rev Gastroenterol Hepatol, 2015). In pathological conditions such as Crohn's disease, their expression is significantly upregulated, particularly in the ileal mucosa, where they serve as receptors for the FimH adhesin of Adherent-Invasive Escherichia coli (AIEC) (Spaeth et al., PLoS One, 2013). This pathogen-host interaction facilitates bacterial colonization, invasion, and the subsequent inflammatory response characteristic of inflammatory bowel disease. Therapeutic strategies, such as the use of D-mannose or the FimH antagonist Sibofimloc (EB8018), aim to competitively inhibit this binding, thereby preventing bacterial attachment and reducing mucosal inflammation (Enterome, 2023). These glycoproteins represent a critical interface for host-microbe interactions and a novel focal point for anti-adhesive therapies in gastroenterology.

Other names
Mannosylated intestinal glycoproteinsMannose-containing glycoconjugatesCEACAM6CD66cCarcinoembryonic antigen-related cell adhesion molecule 6
02

Mechanism of action

Competitive inhibition of bacterial FimH adhesin binding to host mannose-containing glycoproteins

03

Biological functions

Cell-cell adhesionPathogen recognitionInnate immune responseSignal transduction
04

Disease associations

Crohn's diseaseInflammatory bowel diseaseEnteric infection
05

Safety considerations

Potential for altering the composition of the commensal gut microbiotaTheoretical risk of interfering with endogenous mannose-binding lectin (MBL) functions in the immune system
06

Interacting drugs

D-mannose

2 more in the full profile.

07

Biomarkers

CEACAM6 expression in ileal biopsiesAdherent-Invasive Escherichia coli (AIEC) mucosal load

Beyond the preview

Go deeper on Intestinal epithelial cell surface mannose-containing glycoproteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal epithelial cell surface mannose-containing glycoproteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call